In order to reinforce the national COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of 5 booths on station forecourts. COVID mobile screening units are opening today on the forecourts of Bordeaux Saint-Jean and Marseille Saint-Charles stations, following the deployment of the first two boxes in front of Paris Gare de Lyon and Paris-Est stations on November 5. A fifth box will soon be installed near Rennes station.
Category : Press releases
LOXAMED, IN PARTNERSHIP WITH SNCF GARES & CONNEXIONS, INSTALLS "MOBILTEST" COVID-19 SCREENING BOOTHS ON FIVE STATION FORECOURTS
To reinforce the national COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of 5 booths on station forecourts. Mobile COVID screening units will be installed on November 5 in front of Paris Gare de Lyon and Paris Est stations. The station forecourts at Marseille Saint-Charles and Bordeaux Saint-Jean, followed by Rennes, will soon be equipped with screening booths.
Doxamed (ex Loxamed) is proud to announce that it is installing the first on-board diagnostics and screening unit, on board the "We love 2023" train built by the SNCF for the upcoming Rugby World Cup in France.
On the occasion of the inauguration of the "We love 2023" train, deployed by SNCF as part of the Rugby World Cup 2023, Doxamed (formerly Loxamed) presented its Covid testing and diagnostic unit, which will be installed in one of the train's carriages. During the train visit, the Mayor of Paris, Anne Hidalgo, underlined "the effectiveness of the Doxamed (ex Loxamed) device", which she had tested in Paris in the 19th arrondissement, as part of the screening of migrant workers.
Doxamed (formerly Loxamed) is proud to be playing an active role in strengthening screening resources in the Ile-de-France region, with the deployment of two MobilTests mobile screening trucks, which will criss-cross the entire region.
Doxamed (formerly Loxamed) has been chosen by the Ile-de-France region to reinforce its screening policy and make it accessible to all Ile-de-France residents. The Ile-de-France region is facing a deteriorating health situation in its eight departments. An effective screening policy is an essential means of containing the circulation and spread of the virus.
COVID-19: THE ILE-DE-FRANCE REGIONAL HEALTH AGENCY VALIDATES LOXAMED'S HEALTH PROTOCOL
At a time when new outbreaks of contamination are raising fears of a resurgence in the COVID-19 epidemic, the Agence Régionale de Santé (ARS) Ile-de-France has issued a favorable opinion on LOXAMED's Mobile Diagnostic and Screening Unit, which will reinforce the control and fight against the epidemic.
OL presents its return to business and the "OL PROTEGE" scheme
Olympique Lyonnais would like to inform you that it will be resuming its activities on Monday June 8, within a very strict sanitary framework and with respect for the protection of employees' health, which is an absolute priority. The epidemic remains active and the virus is still circulating; it is everyone's responsibility to remain cautious and respect all barrier measures.
COVID-19: A PILOT OF MOBILE DIAGNOSTIC AND SCREENING UNITS IS LAUNCHED IN PARIS' 19TH DISTRICT TO SUPPORT THE DECONFINING PHASE
For over 15 days, a pilot mobile diagnostic and screening unit (UMDD) has been installed in front of a migrant workers' hostel in the 19th arrondissement. This innovative device, devised by LOXAM in partnership with AXAMED laboratories and the TELEDOK medical platform, will be deployed, at the request of the City of Paris, in all the capital's arrondissements to meet the needs of the city and its residents during the decontamination period.